Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10360784" target="_blank" >RIV/00216208:11110/17:10360784 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/17:10360784
Result on the web
<a href="http://dx.doi.org/10.1194/jlr.M072751" target="_blank" >http://dx.doi.org/10.1194/jlr.M072751</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1194/jlr.M072751" target="_blank" >10.1194/jlr.M072751</a>
Alternative languages
Result language
angličtina
Original language name
Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients
Original language description
The purpose of this work was to determine whether changes in cholesterol profiles after interferon- (IFN-)1a treatment initiation following the first demyelinating event suggestive of multiple sclerosis are associated with clinical and MRI outcomes over 4 years. A group of 131 patients (age: 27.9 +/- 7.8 years, 63% female) with serial 3-monthly clinical and 12-monthly MRI follow-ups over 4 years were investigated. Serum cholesterol profiles, including total cholesterol (TC), HDL cholesterol (HDL-C), and LDL cholesterol (LDL-C) were obtained at baseline, 1 month, 3 months, and every 6 months thereafter. IFN-1a initiation caused rapid decreases in serum HDL-C, LDL-C, and TC within 1 month of IFN-1a initiation (all P < 0.001) that returned slowly toward baseline. In predictive mixed model analyses, greater percent decreases in HDL-C after 3 months of IFN-1a treatment initiation were associated with less brain atrophy over the 4 year time course, as assessed by percent brain volume change (P < 0.001), percent gray matter volume change (P < 0.001), and percent lateral ventricle volume change (P = 0.005). Decreases in cholesterol biomarkers following IFN-1a treatment are associated with brain atrophy outcomes over 4 years. Pharmacological interventions targeting lipid homeostasis may be clinically beneficial for disrupting neurodegenerative processes.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Lipid Research
ISSN
0022-2275
e-ISSN
—
Volume of the periodical
58
Issue of the periodical within the volume
2
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
403-411
UT code for WoS article
000395108900010
EID of the result in the Scopus database
2-s2.0-85011284377